Skip to main content
. 2024 Aug 2;14:17899. doi: 10.1038/s41598-024-68134-y

Table 2.

logistic analysis of the association between slamf9 expression and clinical characteristics.

Characteristics Total (N) OR (95% CI) P value
Pathologic T stage (T3&T4 vs. T1&T2) 641 1.898 (1.279–2.815) 0.001
Pathologic N stage (N2&N1 vs. N0) 640 1.486 (1.084–2.036) 0.014
Pathologic M stage (M1 vs. M0) 564 1.262 (0.801–1.988) 0.316
Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II) 623 1.477 (1.074–2.029) 0.016
Gender (Male vs. Female) 644 1.119 (0.821–1.525) 0.477
Age (> 65 vs. <= 65) 644 1.079 (0.790–1.474) 0.633
CEA level (> 5 vs. <= 5) 415 1.361 (0.912–2.030) 0.131

P < 0.05, and the results were statistically significant.